Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NC-503 in Type 2 Diabetes and Metabolic Syndrome
NCT00675857Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2008
- Primary completion
- Jan 2010
- Countries
- 1
01
Overview
A Phase 2 trial of eprodisate in type 2 diabetes mellitus (T2DM), sponsored by GSK. Started Apr 2008; status: completed.
02
Drugs
eprodisate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00675857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675857.